APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 170 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $19,531,000 | +48.0% | 309,031 | +0.5% | 0.02% | +40.0% |
| Q1 2021 | $13,198,000 | -27.7% | 307,575 | -3.6% | 0.02% | -31.8% |
| Q4 2020 | $18,256,000 | +368.0% | 319,154 | +146.8% | 0.02% | +340.0% |
| Q3 2020 | $3,901,000 | -87.8% | 129,319 | -86.8% | 0.01% | -88.4% |
| Q2 2020 | $31,998,000 | +8.2% | 979,716 | -11.3% | 0.04% | -12.2% |
| Q1 2020 | $29,586,000 | -30.7% | 1,104,349 | -20.8% | 0.05% | -16.9% |
| Q4 2019 | $42,693,000 | +61.5% | 1,394,285 | +27.1% | 0.06% | +47.5% |
| Q3 2019 | $26,431,000 | – | 1,097,202 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |